Interventional Oncology Devices – Market Insights – Latin America

The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors, supported by growing reimbursement for devices. However, growth will be somewhat limited by the strict guidelines, a lack of regional clinical evidence, financial constraints, and the uneven distribution of care across Latin American countries.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Latin American region from 2019 through 2034.

The ablation device market is dominated by RF ablation; however, new technologies like cryoablation and microwave ablation are increasingly being used.

What factors are driving growth within the microwave and cryoablation ablation device segment?

What are the advantages and disadvantages of each type of ablation device, and how do these differences affect adoption for different indications?

What is the current status of device availability in the geographies covered?

How does the uptake of microwave ablation devices affect other types of ablation devices, like RF ablation devices, and how are competitors preparing for this shift?

What are the strategies employed by key competitors to position themselves in the ablation device market, and what challenges do they face? Which competitors are leaving certain market segments?

How will resection and embolization devices compete against RF ablation? How are clinical guidelines and growing evidence impacting the adoption of ablative technologies for the covered indications?

Microspheres, DEBs, and radioembolization spheres are seeing increasing adoption.

How are premium priced products like DEBs and radioembolization spheres performing in Latin America?

What are the major barriers for their adoption?

How will the results from clinical trials like LEGACY and DOORWaY-90 expected to influence the adoption of radioembolization spheres in cancer treatment?

How will the market growth vary across different embolization device categories?

The launch of new products will drive the growth of Latin American interventional oncology device market.

What new products are anticipated to be launched in Latin America?

How are new product launches shaping growth in the Latin American interventional oncology market?